<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05334</article-id><article-id pub-id-type="doi">10.7554/eLife.05334</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>A mutant <italic>Escherichia coli</italic> that attaches peptidoglycan to lipopolysaccharide and displays cell wall on its surface</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-20797"><name><surname>Grabowicz</surname><given-names>Marcin</given-names></name><aff><institution content-type="dept">Department of Molecular Biology</institution>, <institution>Princeton University</institution>, <addr-line><named-content content-type="city">Princeton</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21149"><name><surname>Andres</surname><given-names>Dorothee</given-names></name><aff><institution content-type="dept">Department of Chemistry and Chemical Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21150"><name><surname>Lebar</surname><given-names>Matthew D</given-names></name><aff><institution content-type="dept">Department of Chemistry and Chemical Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21153"><name><surname>Malojčić</surname><given-names>Goran</given-names></name><aff><institution content-type="dept">Department of Chemistry and Chemical Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21152"><name><surname>Kahne</surname><given-names>Daniel</given-names></name><aff><institution content-type="dept">Department of Chemistry and Chemical Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5970"><name><surname>Silhavy</surname><given-names>Thomas J</given-names></name><aff><institution content-type="dept">Department of Molecular Bioloy</institution>, <institution>Princeton University</institution>, <addr-line><named-content content-type="city">Princeton</named-content></addr-line>, <country>United States</country><email>tsilhavy@princeton.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1098"><name><surname>Groisman</surname><given-names>Eduardo A</given-names></name><role>Reviewing editor</role><aff><institution>Yale University/HHMI</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>12</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e05334</elocation-id><supplementary-material><ext-link xlink:href="elife-05334-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>29</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>© 2014, Grabowicz et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Grabowicz et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The lipopolysaccharide (LPS) forms the surface-exposed leaflet of the outer membrane (OM) of Gram-negative bacteria, an organelle that shields the underlying peptidoglycan (PG) cell wall. Both LPS and PG are essential cell envelope components that are synthesized independently and assembled by dedicated transenvelope multiprotein complexes. We have identified a point-mutation in the gene for O-antigen ligase (WaaL) in Escherichia coli that causes LPS to be modified with PG subunits, intersecting these two pathways. Synthesis of the PG-modified LPS (LPS*) requires ready access to the small PG precursor pool but does not weaken cell wall integrity, challenging models of precursor sequestration at PG assembly machinery. LPS* is efficiently transported to the cell surface without impairing OM function. Because LPS* contains the canonical vancomycin binding site, these surface- exposed molecules confer increased vancomycin-resistance by functioning as molecular decoys that titrate the antibiotic away from its intracellular target. This unexpected LPS glycosylation fuses two potent pathogen-associated molecular patterns (PAMPs).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>